−8.7SEK
−466.19 MSEK
1.21 BSEK
38.11 M
About CALLIDITAS THERAPEUTICS AB SER'B'NPV
Sector
CEO
Renée Julie Elisabet Aguiar-Lucander
Headquarters
Stockholm
Website
Founded
2004
ISIN
SE0010441584
FIGI
BBG00Y4QYB65
Calliditas Therapeutics AB clinical-stage biopharmaceutical company. It engages in the identification, development, and commercialization of novel treatments in orphan indications. The firm focuses on renal and hepatic diseases with significant unmet medical needs. It offers Nefecon, a proprietary, novel oral formulation of budesonide for the treatment of the autoimmune renal disease IgA nephropathy, or IgAN. The firm product TARPEYO is used to reduce proteinuria in adults with primary immunoglobulin. The company was founded by Mikael Bender and Bengt Åke Julander on February 20, 2004 and is headquartered in Stockholm, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0A5R is 101.0 SEK — it has decreased by 3.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange CALLIDITAS THERAPEUTICS AB SER'B'NPV stocks are traded under the ticker 0A5R.
CALLIDITAS THERAPEUTICS AB SER'B'NPV is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for CALLIDITAS THERAPEUTICS AB SER'B'NPV has a max estimate of 300.0 SEK and a min estimate of 89.9 SEK.
0A5R earnings for the last quarter are −0.17 SEK whereas the estimation was −0.71 SEK which accounts for 76.18% surprise. Estimated earnings for the next quarter are −0.94 SEK. See more details about CALLIDITAS THERAPEUTICS AB SER'B'NPV earnings.
CALLIDITAS THERAPEUTICS AB SER'B'NPV revenue for the last quarter amounts to 294.60 M SEK despite the estimated figure of 325.23 M SEK. In the next quarter revenue is expected to reach 360.45 M SEK.
Yes, you can track CALLIDITAS THERAPEUTICS AB SER'B'NPV financials in yearly and quarterly reports right on TradingView.
Like other stocks, 0A5R shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CALLIDITAS THERAPEUTICS AB SER'B'NPV stock right from TradingView charts — choose your broker and connect to your account.